Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack.10 vs 30 Days of Combination ASA and Clopidogrel Study

NCT02144831 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT02144831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02144831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack.10 vs 30 Days of Combination ASA and Clopidogrel Study
Lead sponsor
University of Alberta
Phase
Phase 4
Overall status
Withdrawn
Start date
July 31, 2014
Completion date
October 31, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

minor stroke, transient ischemic attacks